Cardinal Health CAH Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cost of product sold | $12.79B+1.9% | $12.8B+2.4% | $12.7B+1.8% | $12.64B+2.1% | $12.55B+1.6% | |
| Other Segments | $6.68B+35.1% | $6.28B+30.9% | $5.84B+25.6% | $5.38B+19.3% | $4.95B+14.4% | |
| Pharmaceutical and Specialty Solutions | $231.36B+12.9% | $225.68B+10.1% | $215.86B+4.1% | $204.64B-2.6% | $204.88B+0.5% | |
| Revenue by Geography | ||||||
| Non-US | $1.71B+2.1% | $1.69B-0.8% | $1.68B-0.5% | $1.67B-0.7% | $1.68B— | |
| UNITED STATES | $249.12B+12.9% | $243.07B+10.2% | $232.71B+4.4% | $220.99B-1.9% | $220.7B-0.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cardinal Health break its business down?
- Cardinal Health (CAH) reports revenue by business across 3 parts — Cost of product sold, Other Segments and Pharmaceutical and Specialty Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Cardinal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cardinal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
